Journal
Journal of Allergy and Clinical Immunology
Publication Date
9-1-2024
Volume
154
Issue
3
First Page
580
Last Page
591.e6
Document Type
Open Access Publication
DOI
10.1016/j.jaci.2024.03.023
Rights and Permissions
Tang M, Charbit AR, Johansson MW, Jarjour NN, Denlinger LC, Raymond WW, Peters MC, Dunican EM, Castro M, Sumino K, Erzurum SC, Comhair SA, Moore WC, Levy BD, Israel E, Phipatanakul W, Phillips BR, Mauger DT, Bleecker ER, Wenzel SE, Fajt ML, Woodruff PG, Hastie AT, Fahy JV; National Heart Lung and Blood Institute Severe Asthma Research Program. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma. J Allergy Clin Immunol. 2024 Sep;154(3):580-591.e6. doi: 10.1016/j.jaci.2024.03.023. Copyright 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Recommended Citation
Tang, Monica; Sumino, Kaharu; and et al., "Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma." Journal of Allergy and Clinical Immunology. 154, 3. 580 - 591.e6. (2024).
https://digitalcommons.wustl.edu/oa_4/5321
Department
ICTS (Institute of Clinical and Translational Sciences)
